Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials To view or add a comment, sign in More Relevant Posts The upheaval of the Health and Human Services workforce and leadership leaves much to be desired in terms of delivery, recently retired FDA Chief Information Officer Vid Desai tells BioSpace, but the regulatory agency is evolving to be more open to much needed change
But if you eat salad every day and dont vary it, youll be stable
While less potent than injectable options, the convenience of oral administration could make it a preferred first-line option
While manufacturers provide specific timing recommendations in FDA labeling, individual patient factors may influence the most appropriate administration time
When speaking to your doctor, it may be helpful to: Explain your weight management history , including previous treatments tried, their outcomes, and any underlying health conditions such as type 2 diabetes, cardiovascular disease, or obstructive sleep apnoea